share_log

BRIEF-GlobeImmune Celgene Corporation entered into Celgene amendment' agreement

路透新闻 ·  Aug 5, 2015 11:22

Aug 4 (Reuters) - GlobeImmune Inc (GBIM.O) :

* Says on July 31, 2015 co and Celgene Corporation entered into Celgene amendment' agreement

* Says Celgene amendment provides company's gi-6100 program replaced the company's gi-3000 program as a drug candidate

* Globeimmune -co eligible for milestone payments of up to $145 mln,and tiered royalty payments in the low teens for sales of gi-6100

* Source text for Eikon

* Further company coverage (GBIM.O)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment